Role of mi-RNAs in Diagnosing APP and BACE-1 Targeted Cognitive Deficits of Alzheimer's Disease

被引：0
|
作者：
Basavaraju, Preethi [1 ]
Sreedharam, Sindhu [1 ]
Babu, Kavipriya [1 ]
Devaraj, Ilakkiyapavai [1 ]
Puthamohan, Vinayaga Moorthi [1 ,2 ]
机构：
[1] Bharathiar Univ, Dept Human Genet & Mol Biol, Biomat & Nanomed Lab, Coimbatore 641046, Tamil Nadu, India
[2] Bharathiar Univ, Dept Human Genet & Mol Biol, Coimbatore 641046, Tamil Nadu, India
来源：
INTERNATIONAL JOURNAL OF HUMAN GENETICS | 2023年 / 23卷 / 2-3期
关键词：
Alzheimer's Disease; Amyloid Deposition; Amyloid Precursor Protein; Circulating miRNAs; Cognitive Health; Neuroinflammation; TRIBAL POPULATIONS; SOUTHERN INDIA; INSERTION/DELETION POLYMORPHISMS; CONGRUENCE; AFFINITIES;
D O I：
10.31901/24566322.2023/23.2-3.855
中图分类号：
Q3 [遗传学];
学科分类号：
071007 ; 090102 ;
摘要：
miRNAs play vital pro-survival roles in regulating anti-inflammatory and memory based signalling cascades of the central nervous system. Amongst which, selective miRNAs including miR-17, miR-16, miR-101, miR132, miR-31 and many more are studied as the post-transcriptional regulators of several conditions like Alzheimer's disease (AD). In the present study a total of 32 subjects comprising of 16 AD cohorts and 16 age adjusted control subjects were chosen from south Indian region (Coimbatore), screened for the APOE isoform incidence and the hippocampal amyloid deposition cascade associated relative expression of two major circulating miRNAs on APP and BACE-1 genes. In addition, cognitive health of individual subjects was also calculated based on the MMSE tool. The outcome strongly portrayed that there exists a positive correlation between the relative up regulation and down regulation of miRNAs miR-132 and miR-31 on APP and BACE-1 targeted cognitive deficits seen in the elderly aged AD women.
引用
收藏
页码：177 / 183
页数：7
相关论文
共 50 条
  • [1] BACE-1 Inhibitors Targeting Alzheimer's Disease
    Monteiro, Kadja Luana Chagas
    Alcantara, Marcone Gomes dos Santos
    Freire, Nathalia Monteiro Lins
    Brandao, Esau Marques
    do Nascimento, Vanessa Lima
    Viana, Libni Maisa dos Santos
    de Aquino, Thiago Mendonca
    da Silva-Junior, Edeildo Ferreira
    CURRENT ALZHEIMER RESEARCH, 2023, 20 (03) : 131 - 148
  • [2] BACE-1 and γ-Secretase as Therapeutic Targets for Alzheimer's Disease
    Maia, Miguel A.
    Sousa, Emilia
    PHARMACEUTICALS, 2019, 12 (01)
  • [3] The physical approximation of APP and BACE-1: A key event in alzheimer's disease pathogenesis
    Sun, Jichao
    Roy, Subhojit
    DEVELOPMENTAL NEUROBIOLOGY, 2018, 78 (03) : 340 - 347
  • [4] Icariin Decreases the Expression of APP and BACE-1 and Reduces the β-amyloid Burden in an APP Transgenic Mouse Model of Alzheimer's Disease
    Zhang, Lan
    Shen, Cong
    Chu, Jin
    Zhang, Ruyi
    Li, Yali
    Li, Lin
    INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES, 2014, 10 (02): : 181 - 191
  • [5] The BACE-1 inhibitor CNP520 for prevention trials in Alzheimer's disease
    Neumann, Ulf
    Ufer, Mike
    Jacobson, Laura H.
    Rouzade-Dominguez, Marie-Laure
    Huledal, Gunilla
    Kolly, Carine
    Luond, Rainer M.
    Machauer, Rainer
    Veenstra, Siem J.
    Hurth, Konstanze
    Rueeger, Heinrich
    Tintelnot-Blomley, Marina
    Staufenbiel, Matthias
    Shimshek, Derya R.
    Perrot, Ludovic
    Frieauff, Wilfried
    Dubost, Valerie
    Schiller, Hilmar
    Vogg, Barbara
    Beltz, Karen
    Avrameas, Alexandre
    Kretz, Sandrine
    Pezous, Nicole
    Rondeau, Jean-Michel
    Beckmann, Nicolau
    Hartmann, Andreas
    Vormfelde, Stefan
    David, Olivier J.
    Galli, Bruno
    Ramos, Rita
    Graf, Ana
    Lopez, Cristina Lopez
    EMBO MOLECULAR MEDICINE, 2018, 10 (11)
  • [6] Semi-synthetic isoflavones as BACE-1 inhibitors against Alzheimer's disease
    Ribaudo, Giovanni
    Coghi, Paolo
    Zanforlin, Enrico
    Law, Betty Yuen Kwan
    Wu, Yuki Yu Jun
    Han, Yu
    Qiu, Alena Congling
    Qu, Yuan Qing
    Zagotto, Giuseppe
    Wong, Vincent Kam Wai
    BIOORGANIC CHEMISTRY, 2019, 87 : 474 - 483
  • [7] Alzheimer's-related endosome dysfunction in Down syndrome is Aβ-independent but requires APP and is reversed by BACE-1 inhibition
    Jiang, Ying
    Mullaney, Kerry A.
    Peterhoff, Corrinne M.
    Che, Shaoli
    Schmidt, Stephen D.
    Boyer-Boiteau, Anne
    Ginsberg, Stephen D.
    Cataldo, Anne M.
    Mathews, Paul M.
    Nixon, Ralph A.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2010, 107 (04) : 1630 - 1635
  • [8] BACE-1 is expressedin the blood-brain barrier endothelium and is upregulated in a murine model of Alzheimer's disease
    Devraj, Kavi
    Poznanovic, Slobodan
    Spahn, Christoph
    Schwall, Gerhard
    Harter, Patrick N.
    Mittelbronn, Michel
    Antoniello, Katia
    Paganetti, Paolo
    Muhs, Andreas
    Heilemann, Mike
    Hawkins, Richard A.
    Schrattenholz, Andre
    Liebner, Stefan
    JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2016, 36 (07) : 1281 - 1294
  • [9] An Insight into Medicinal Chemistry and SAR Studies of Cholinesterase and BACE-1 Inhibitors for Alzheimer's Disease
    Shome, Abhimannu
    Jha, Keshav Taruneshwar
    Chawla, Viney
    Chawla, Pooja A.
    CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2024,
  • [10] Concatenation of molecular docking and molecular simulation of BACE-1, γ-secretase targeted ligands: in pursuit of Alzheimer's treatment
    Jabir, Nasimudeen R.
    Rehman, Md Tabish
    Alsolami, Khadeejah
    Shakil, Shazi
    Zughaibi, Torki A.
    Alserihi, Raed F.
    Khan, Mohd Shahnawaz
    AlAjmi, Mohamed F.
    Tabrez, Shams
    ANNALS OF MEDICINE, 2021, 53 (01) : 2332 - 2344
12345